MetLife Inc.
MET | NYSE
$97.34
+$1.42 (+1.48%)
At close: Sep 23, 2026, 3:43 PM ET
$96.40
-$0.94 (-0.97%)
After-hours:
Sep 23, 2026, 7:19 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 77.08B | 69.94B | 67.71B | 67.97B | 63.37B | 67.89B |
Cost of Revenue | 49.06B | 50.94B | 50.42B | 49.03B | 46.53B | 52.42B |
Gross Profit | 28.02B | 19B | 17.29B | 18.94B | 16.84B | 15.47B |
Operating Income | 4.66B | 5.62B | 2.16B | 6.36B | 8.52B | 6.93B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 4.66B | 5.62B | 2.16B | 6.36B | 8.52B | 6.93B |
Net Income | 3.38B | 4.43B | 1.58B | 5.28B | 6.86B | 5.41B |
Selling & General & Admin | n/a | 5.99B | 6.18B | 5.86B | 5.76B | 5.78B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 23.36B | 7.39B | 8.95B | 6.71B | 2.56B | 2.77B |
Operating Expenses | 23.36B | 13.38B | 15.13B | 12.57B | 8.32B | 8.54B |
Interest Expense | 1.06B | 1.04B | 1.05B | 938M | 920M | 913M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 72.42B | 64.32B | 65.55B | 61.6B | 54.85B | 60.96B |
Income Tax Expense | 1.26B | 1.18B | 560M | 1.06B | 1.64B | 1.51B |
Shares Outstanding (Basic) | 664.96M | 689.21M | 762.43M | 779.1M | 825.54M | 892.91M |
Shares Outstanding (Diluted) | 664.96M | 711.1M | 762.43M | 808.9M | 869.4M | 913.2M |
EPS (Basic) | 4.80 | 5.98 | 1.82 | 6.35 | 7.70 | 5.72 |
EPS (Diluted) | 4.80 | 5.94 | 1.81 | 6.30 | 7.65 | 5.68 |
EBITDA | 6.48B | 7.37B | 3.93B | 7.98B | 10.13B | 8.46B |
EBIT | 5.72B | 6.66B | 3.21B | 7.3B | 9.44B | 7.84B |
Depreciation & Amortization | 753M | 714M | 718M | 673M | 694M | 619M |
Add to Watchlist
Select watchlists to add or remove MET